Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
3.570
+0.200 (5.93%)
Jul 30, 2026, 9:55 AM EDT - Market open
Cryo-Cell International Ratios and Metrics
Market cap in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
| 29 | 35 | 70 | 44 | 37 | 106 | |
Market Cap Growth | -27.31% | -50.57% | 58.05% | 19.35% | -64.91% | 87.08% |
Enterprise Value | 32.97 | 42.9 | 79.51 | 54.25 | 47.04 | 100.35 |
Last Close Price | 3.57 | 4.30 | 8.67 | 5.35 | 4.37 | 12.38 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
PE Ratio | - | - | 173.40 | - | 13.24 | 49.52 |
Forward PE | 30.64 | 56.00 | 78.82 | 252.00 | 48.56 | - |
PS Ratio | 0.87 | 1.10 | 2.19 | 1.41 | 1.22 | 3.67 |
PB Ratio | - | -1.86 | -5.30 | -4.02 | -24.37 | 25.30 |
P/FCF Ratio | 4.45 | 6.60 | 19.43 | 21.31 | - | 17.38 |
P/OCF Ratio | 4.30 | 6.32 | 11.66 | 4.97 | 4.33 | 13.36 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
EV/Sales Ratio | 1.06 | 1.36 | 2.49 | 1.73 | 1.55 | 3.47 |
EV/EBITDA Ratio | 37.84 | 29.23 | 19.05 | - | 8.52 | 19.84 |
EV/EBIT Ratio | - | 88.93 | 22.85 | - | 11.69 | 24.97 |
EV/FCF Ratio | 5.40 | 8.17 | 22.04 | 26.07 | - | 16.47 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Debt / Equity Ratio | -0.47 | -0.59 | -0.93 | -0.95 | -7.33 | 0.15 |
Debt / EBITDA Ratio | 10.29 | 7.88 | 3.10 | - | 2.10 | 0.56 |
Debt / FCF Ratio | 1.47 | 2.20 | 3.59 | 5.24 | - | 0.46 |
Net Debt / Equity Ratio | -0.33 | -0.44 | -0.71 | -0.90 | -6.49 | -1.32 |
Net Debt / EBITDA Ratio | 6.66 | 5.63 | 2.26 | -0.91 | 1.79 | -1.09 |
Net Debt / FCF Ratio | 0.95 | 1.57 | 2.62 | 4.76 | -2.75 | -0.91 |
Asset Turnover | 0.51 | 0.50 | 0.51 | 0.50 | 0.48 | 0.54 |
Inventory Turnover | 19.11 | 13.83 | 11.14 | 10.36 | 9.92 | 9.73 |
Quick Ratio | 0.63 | 0.51 | 0.50 | 0.36 | 0.40 | 0.64 |
Current Ratio | 0.71 | 0.59 | 0.58 | 0.45 | 0.49 | 0.75 |
Return on Equity (ROE) | 13.56% | 15.27% | -3.32% | 151.67% | 208.38% | 274.30% |
Return on Assets (ROA) | -0.16% | 0.79% | 0.79% | -13.90% | 5.35% | 6.00% |
Return on Invested Capital (ROIC) | -0.23% | 1.18% | 1.20% | -20.44% | 15.25% | 22.54% |
Return on Capital Employed (ROCE) | -0.24% | 1.13% | 8.34% | -28.69% | 9.47% | 11.58% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Earnings Yield | - | - | 0.58% | - | 7.55% | 2.02% |
FCF Yield | 22.49% | 15.15% | 5.15% | 4.69% | - | 5.75% |
Dividend Yield | - | 9.31% | 2.87% | 0.00% | 20.74% | 0.00% |
Payout Ratio | - | -133.01% | 502.50% | 0.00% | 276.85% | 0.00% |
Buyback Yield / Dilution | 0.21% | 1.75% | 1.54% | 1.69% | -1.46% | -2.72% |
Total Shareholder Return | 0.21% | 11.06% | 4.40% | 1.69% | 19.28% | -2.72% |